Skip to content

Effectiveness of Unified Protocol for Transdiagnostic Treatment in Children with Anxiety Disorders

Effectiveness of Unified Protocol for Transdiagnostic Treatment in Children with Anxiety Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210723051963N1
Enrollment
30
Registered
2021-11-06
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Social phobias. Condition 2: Generalized anxiety disorder. Condition 3: Specific (isolated) phobias. Condition 4: Separation anxiety disorder of childhood. Condition 5: Panic disorder. Condition 6: Agoraphobia. Social phobias Generalized anxiety disorder Specific (isolated) phobias Separation anxiety disorder of childhood Panic disorder [episodic paroxysmal anxiety] without agoraphobia Agoraphobia

Interventions

Intervention 1: Intervention group: Unified Protocol for Transdiagnostic Treatment in Children (UP-C). Intervention 2: Control group: Cognitive Behavior Therapy.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age between 8 and 12 Receive a diagnosis of anxiety disorder based on a KSADS-PL diagnostic interview Do not take psychiatric medication to treat anxiety disorders

Exclusion criteria

Exclusion criteria: Co-occurrence of depressive disorder based on KSADS-PL diagnostic interview. Existence of developmental neurological disorders such as autism spectrum disorder and mental retardation based on parental report and KSADS-PL diagnostic interview. History of receiving psychotherapy for anxiety disorders in the last 2 years Existence of serious suicidal ideation in KSADS-PL5 diagnostic interview. Diagnosis or history of bipolar disorder or psychosis based on KSADS-PL diagnostic interview. Diagnosis of externalized disorders (coping disorders, conduct and attention deficit hyperactivity disorder) based on KSADS-PL diagnostic interview. Get a diagnosis or previous history of reading disorders

Design outcomes

Primary

MeasureTime frame
Anxiety Symptoms in Children. Timepoint: Beginning of study, end of study, follow-up after three months. Method of measurement: Screen for Child Anxiety Related Disorders & Kiddie Schedule for Affective Disorders and Schizophrenia and.;Emotion Regulation. Timepoint: Beginning of study, end of study, follow-up after three months. Method of measurement: Emotion Regulation Questionnaire for Children and Adolescents & Children's Emotional Management Scales.;Cognitive reappraisal. Timepoint: Beginning of study, end of study, follow-up after three months. Method of measurement: Emotion Regulation Questionnaire for Children and Adolescents.;Expressive suppression. Timepoint: Beginning of study, end of study, follow-up after three months. Method of measurement: Emotion Regulation Questionnaire for Children and Adolescents.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPantea Ahadianfard

Iran University of Medical Sciences

pantea.ahadian@gmail.com+98 21 6655 1655

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026